Loading...

FISCHER Fischer Medical Ventures Ltd Business Restructuring Announcement

Fsch

FSCH

Fischer Medical Ventures Ltd

(FISCHER)

2026 Announcement

Regulatory disclosure

Conversion of warrants

Trading Window Closure

Trading Window Closure

Re-lodgement Window

Asset Acquisition

Monitoring Agency Report

New Product Launch

Promotion of encumbrance di...

Creation of encumbrance

Key Managerial Resignation

Shareholding restructuring

Shareholding restructuring

Shareholding restructuring

Intra-group transfer

Transfer of securities

Regulatory Compliance

Committee reconstitution

Trading Window Closure

Geographic Expansion

Price movement clarification

New Product Launch

Earnings call transcript

Geographic Expansion

Geographic Expansion

Investor Meet Outcome

New MRI Development

Investor Call Scheduled

FlynnCare Silver Medal

Postal Ballot Notice

Corporate Presentation Update

Income Surge Report

Postal Ballot Update

Management Change

Financial Results

Board Meeting Outcomes

Monitoring Report Released

Board Meeting Notice

Market Expansion Update

Licensing Achieved

Subsidiary Investment

Compliance Certificate

Dividend Clarification

Annual General Meeting

Board Meeting Outcome

Director Resignation

Monitoring Agency Report

Postal Ballot Notice

First MRI Facility

Tuberculosis Initiative

Award Win Announcement

Fight Against TB

Property Acquisition

Compliance Certificate

Annual Compliance Report

Monitoring Report Received

Investment Update

Management Appointment

Investment Approved

Investment Approval

Promoter Shareholding Update

ISIN Allotment Update

Equity Shares Allotted

SEBI Compliance Cert.

Investment Update

Trading Window Closure

Director Resignation

Committee Reconstitution

Director Resignation

Loan Agreement Update

New MD Appointment

Investment in Subsidiary

Office Address Change

Rights Issue Investment

Investment Plans

Regulatory Disclosure

New Subsidiary Incorporated

Equity Shares Allotment

Audit Committee Update

MRI Machines Supply

EGM Results Announced

EGM Meeting Update

AI Healthcare Solutions

Sikkim MRI Project

MRI License Granted

Regulatory Compliance

Extra Ordinary Meeting

Board Meeting Outcomes

Investor Presentation

Board Meeting Update

Equity Share Withdrawal

Management Update

Office Relocation

New Subsidiary Formed

Board Meeting Announcement

New Subsidiary Established

Board Meeting Results

Compliance Certificate

New Subsidiary Established

New Subsidiary Established

Board Meeting Outcome

Health Program Collaboration

Email Update Notice

Board Meeting Update

Fund Utilization Update

Director Appointment

Board Restructuring

Board Meeting Update

Partnership Announcement

Subsidiary Incorporation

Collaboration Announcement

Firm Up Marketing Rights

Investment in Sascan Medite...

Partnership Announcement

Regulation 74 (5) Certifica...

Change in Directorate

Investment Update

Partnership Announcement

Registered Office Change

Partnership Announcement

Investment Firm Up

Designated Person Update

Strategic Partnership Annou...

Change of Office Address

Newspaper Advertisement

Partnership Announcement

Compliances-Reg.24(A)-Annua...

Revolutionizing Global Heal...

Healthcare Innovation

Management Changes

Office Address Change

Management Changes

Compliance Certificate Subm...

MRI Components Agreement

Compliance Certificate Anno...

Compliance Certificate Subm...

FISCHER CHEMIC LTD.

FISCHER CHEMIC LTD. - Recom...

Outcome Meeting Independent...

Open Offer Approval

Letter of Offer Submission

Publication of Financial Re...

Statement of Deviation/Vari...

ISIN Allocation

Acquisition of Time Medical...

Allotment of Securities

Certificate Submission

Open Offer for Fischer Chem...

Acquisition and Other Appro...

Appointment and Key Decisions

Approval for Reclassificati...

Funds Deviation

Regulation 74(5) Certificate

Financial Statements

Financial Statements

Financial Reporting

Financial Statements public...

Reclassification of Promote...

External Links:

Data:

Fischer Medical Ventures reconstitutes Audit, Nomination & Remuneration, Risk Management, and CSR committees, effective Jan 1, 2026, with independent directors and key executives in new roles.

AI Assistant

Fischer Medical Ventures Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.